Ye Yuan
RayzeBio, Inc. · RayzeBio Sr. Medical Director
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ye Yuan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:48 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07165132 · Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.RayzeBio, Inc. · recruiting · GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease · study director
- Ph3NCT05477576 · Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyRayzeBio, Inc. · active not recruiting · GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:48 UTC. The ranking covers the 200 most relevant of 511 PubMed records, and a shared surname and initials can bring in a namesake. All 511 on PubMed
- A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med · 20203,522 citationsRCR 201.4
- Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.N Engl J Med · 2022909 citationsRCR 75.5
- Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.N Engl J Med · 2020653 citationsRCR 33.4
- Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.N Engl J Med · 2022580 citationsRCR 37.9
- 384 citationsRCR 22.8
- 379 citationsRCR 11.7
- Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial.Ophthalmology · 2022275 citationsRCR 38.7
- Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial.J Clin Oncol · 2021259 citationsRCR 13.2
- 238 citationsRCR 17.2
- CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.Nat Med · 2025231 citationsRCR 48.7